[go: up one dir, main page]

AU2002218400A1 - 3-substituted 2,7-naphthyridin-1-yl derivatives - Google Patents

3-substituted 2,7-naphthyridin-1-yl derivatives

Info

Publication number
AU2002218400A1
AU2002218400A1 AU2002218400A AU1840002A AU2002218400A1 AU 2002218400 A1 AU2002218400 A1 AU 2002218400A1 AU 2002218400 A AU2002218400 A AU 2002218400A AU 1840002 A AU1840002 A AU 1840002A AU 2002218400 A1 AU2002218400 A1 AU 2002218400A1
Authority
AU
Australia
Prior art keywords
naphthyridin
derivatives
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002218400A
Inventor
John Clifford Head
Catherine Mckay
John Robert Porter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celltech R&D Ltd
Original Assignee
Celltech R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech R&D Ltd filed Critical Celltech R&D Ltd
Publication of AU2002218400A1 publication Critical patent/AU2002218400A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002218400A 2000-11-27 2001-11-22 3-substituted 2,7-naphthyridin-1-yl derivatives Abandoned AU2002218400A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0028844.9A GB0028844D0 (en) 2000-11-27 2000-11-27 Chemical compounds
GB0028844 2000-11-27
PCT/GB2001/005168 WO2002042264A1 (en) 2000-11-27 2001-11-22 3-substituted 2,7-naphthyridin-1-yl derivatives

Publications (1)

Publication Number Publication Date
AU2002218400A1 true AU2002218400A1 (en) 2002-06-03

Family

ID=9903922

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002218400A Abandoned AU2002218400A1 (en) 2000-11-27 2001-11-22 3-substituted 2,7-naphthyridin-1-yl derivatives

Country Status (5)

Country Link
US (1) US6593338B2 (en)
EP (1) EP1337534A1 (en)
AU (1) AU2002218400A1 (en)
GB (1) GB0028844D0 (en)
WO (1) WO2002042264A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960597B2 (en) * 2000-06-30 2005-11-01 Orth-Mcneil Pharmaceutical, Inc. Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
US20050176755A1 (en) * 2003-10-31 2005-08-11 Dyatkin Alexey B. Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
EP1720839A1 (en) * 2004-02-10 2006-11-15 Janssen Pharmaceutica N.V. Pyridazinones as antagonists of a4 integrins
US20050209232A1 (en) * 2004-02-10 2005-09-22 Kent Barbay Pyridazinone ureas as antagonists of alpha4 integrins
DE602004021404D1 (en) 2004-12-23 2009-07-16 Gpc Biotech Ag Squaric acid derivatives with antiproliferative activity
US8450348B2 (en) 2007-02-21 2013-05-28 Forma Tm, Llc Derivatives of squaric acid with anti-proliferative activity
RU2529468C2 (en) 2008-06-24 2014-09-27 Топотаргет А/С 1, 2-dihydrocyclobutanedione derivatives as nicotinamide phosphoribosyltransferase inhibitors
PT2760821T (en) 2011-09-02 2018-01-11 Novartis Ag Choline salt of an anti-inflammatory substituted cyclobutenedione compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3938367A (en) 1975-03-28 1976-02-17 Nasa Sampler of gas borne particles
CA2074864A1 (en) * 1991-07-30 1993-01-31 Carmen Almansa Tetralones with pharmacological activity
ES2128774T3 (en) * 1994-11-16 1999-05-16 American Home Prod DIAMINOCICLOBUTEN-3,4-DIONAS.
FI982268L (en) 1998-10-20 2000-04-21 Tomi Jaervinen New prodrugs of nonsteroidal anti-inflammatory carboxylic acids, their preparation and use
EP1140792A1 (en) * 1998-12-14 2001-10-10 American Home Products Corporation 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
US6518283B1 (en) * 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6545013B2 (en) * 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives

Also Published As

Publication number Publication date
GB0028844D0 (en) 2001-01-10
US20020137935A1 (en) 2002-09-26
WO2002042264A1 (en) 2002-05-30
EP1337534A1 (en) 2003-08-27
US6593338B2 (en) 2003-07-15

Similar Documents

Publication Publication Date Title
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU2001294606A1 (en) Substituted azepino(4,5b)indoline derivatives
AU2002361992A1 (en) 1,4-dihydro-1,4-diphenylpyridine derivatives
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU6314900A (en) Biarylurea derivatives
AU2001230537A1 (en) Pyridoxazine derivatives
AU2001231664A1 (en) Indol-3-yl derivatives
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU2002213978A1 (en) Substituted C-cyclohexylmethylamine derivatives
AU3819200A (en) 2,4-diamino-pyrimidine derivatives
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU2001226794A1 (en) Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU2001254661A1 (en) Aminosulfonylbiphenyl derivatives
AU2002215212A1 (en) 1-methylcarbapenem derivatives
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives
AU2001234313A1 (en) Novel phenylheteroalkylamine derivatives
AU2002218400A1 (en) 3-substituted 2,7-naphthyridin-1-yl derivatives
AU2001242772A1 (en) 3-substituted-4-pyrimidone derivatives
AU6262300A (en) Indolinylamide derivatives
AU2001293697A1 (en) N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
AU2002221632A1 (en) 5-amino-1-pentene-3-ol substituted derivatives